stanford medicine

 ARCHIVESnext issue


up front

New Alzheimer’s suspect

The pharmaceutical industry has spent billions of dollars on futile clinical trials directed at treating Alzheimer’s disease by ridding brains of a substance called amyloid plaque. But School of Medicine researchers have identified another mechanism that may lie at the root of Alzheimer’s and other neurodegenerative disorders. MORE . . .

Report card

Most of the students who chose to have their genome tested as part of a groundbreaking Stanford course on personalized medicine reported being pleased with their decision, according to a study by researchers at the School of Medicine. MORE . . .

Stemmed cells

Stanford researcher Irving Weissman, MD, and his lab recently went searching for a kind of stem cell touted as an alternative to those derived from human embryos. The tiny cells, called very small embryonic-like, or VSEL, cells, were reported in 2006 as the only naturally occurring pluripotent cells in adult animals and humans. MORE . . .

Ear whacks

Long-term hearing loss from loud explosions, such as blasts from roadside bombs, may not be as irreversible as previously thought, according to a new study by researchers at the School of Medicine. MORE . . .

Nobel week

Nobel lightning struck twice this year at the medical school. On Oct. 7, Thomas Südhof, MD, professor of molecular and cellular physiology, won the 2013 Nobel Prize in Physiology or Medicine. A scant 48 hours later, Michael Levitt, PhD, professor of structural biology, won the Nobel Prize in Chemistry.MORE . . .

Killer Robots

Drug-resistant superbugs are a well-known enemy to good health, especially in hospitals, with an annual $30 billion price tag estimated by the Centers for Disease Control and Prevention. MORE . . .

Rebuffing rape

In the slums of Nairobi, Kenya, as many as one in four adolescent girls are raped each year. But a recent study shows that a short self-defense course can dramatically reduce the girls’ vulnerability to sexual assault. MORE . . .

All squeak, no scamper?

The vast majority of published animal studies that led to clinical trials of treatments for neurological disorders were either poorly designed or biased in their interpretation, say Stanford study-design expert John Ioannidis, MD, DSc, and an international team of researchers. MORE . . .

more departments

Letter from the dean

Answers to the riddle of premature birth


In airplane crash response, training and teamwork prevailed


©2013 Stanford University  |  Terms of Use  |  About Us